Dallas-based MicroTransponder is looking to treat neurological conditions with its aired Vagus Nerve Stimulation, which is designed to help patients with tinnitus as well as stroke victims. The ...

"We are pleased with CMS's decision to assign the Vivistim procedure to New Technology APC 1580, ensuring appropriate reimbursement for this groundbreaking therapy," said Richard Foust, ...

AUSTIN, Texas, Nov. 17, 2025 /PRNewswire/ -- MicroTransponder ®, Inc., a commercial-stage medical technology company and developer of the breakthrough Vivistim ® Paired VNS™ System for chronic stroke ...

AUSTIN, Texas, June 20, 2022 /PRNewswire/ -- MicroTransponder ®, Inc. closed an oversubscribed $53 million Series E funding round led by US Venture Partners (USVP), a multi-stage investment firm. GPG ...

Its Serenity System is used to treat chronic tinnitus, and its Vivistim System is intended to treat poststroke upper-limb mobility issues. Frank McEachern is the company's CEO. Q: Why did you choose ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min An Austin medical technology ...

US-based MicroTransponder has reported positive long-term results for stroke patients who received the company’s paired vagus nerve stimulation (VNS) therapy. The data, published in the medical ...

AUSTIN, Texas, March 12, 2025 /PRNewswire/ -- Announcing a $65 million Series F financing round, MicroTransponder ®, Inc., one of the fastest-growing stroke companies, is transforming the stroke ...

AUSTIN, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- MicroTransponder, Inc., a commercial-stage medical device company today announced that it has changed its corporate name to Mobia Medical, Inc. ("Mobia ...

MicroTransponder’s Vivistim Paired VNS system is a chest implant that helps chronic ischemic stroke survivors regain motor function in their arms and hands by stimulating the nearby vagus nerve, the ...

AUSTIN, Texas, Jan. 31, 2023 /PRNewswire/ -- MicroTransponder®, Inc. announces that the Centers for Medicare and Medicaid Services (CMS) awarded the Vivistim® Paired VNS™ System transitional ...